Trial Site Detail

 

Drug:
DCC-3116 + Ripretinib
Trial:
A Study of DCC-3116 in Combination with Anticancer Therapies in Participants with Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

AOUC Azienda Ospedaliero - Universitaria Careggi

Largo Giovanni Alessandro Brambilla, 3     
Firenze , 50134
Italy

 

Principal Investigator:
 Lorenzo Antonuzzo, MD
Contact:
 Lorenzo Antonuzzo, MD +39 0557947298 lorenzo.antonuzzo@unifi.it
Activation Status of this Site:
 Active
Notes about this Site:
AOUC Azienda Ospedaliero - Universitaria Careggi Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.